BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $158B
1-Year Est. Return 28.56%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
+$29.8B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
5,168
New
Increased
Reduced
Closed

Top Buys

1 +$2.84B
2 +$1.98B
3 +$1.94B
4
AMZN icon
Amazon
AMZN
+$1.5B
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.22B

Sector Composition

1 Technology 28.74%
2 Consumer Discretionary 11.24%
3 Financials 10.44%
4 Healthcare 9.19%
5 Communication Services 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWRS icon
3951
Global Water Resources
GWRS
$234M
$27.1K ﹤0.01%
3,202
-1,551
AFRI icon
3952
Forafric Global
AFRI
$260M
$27K ﹤0.01%
2,445
+502
QSEAR
3953
Quartzsea Acquisition Corp Rights
QSEAR
$26.9K ﹤0.01%
+119,661
NVCT icon
3954
Nuvectis Pharma
NVCT
$237M
$26.7K ﹤0.01%
3,541
+743
LCTX icon
3955
Lineage Cell Therapeutics
LCTX
$426M
$26.6K ﹤0.01%
15,942
+15,782
BDCIW
3956
BTC Development Corp Warrant
BDCIW
$3.26M
$26.6K ﹤0.01%
+59,118
CARL
3957
Carlsmed
CARL
$321M
$26.6K ﹤0.01%
2,150
-350
VVR icon
3958
Invesco Senior Income Trust
VVR
$474M
$26.5K ﹤0.01%
+8,113
PNBK icon
3959
Patriot National Bancorp
PNBK
$143M
$26.4K ﹤0.01%
14,524
+4,737
IKT icon
3960
Inhibikase Therapeutics
IKT
$228M
$26.4K ﹤0.01%
12,891
-2,749
TCRX icon
3961
TScan Therapeutics
TCRX
$63.6M
$26.4K ﹤0.01%
26,360
-3,510
KGEI
3962
Kolibri Global Energy
KGEI
$164M
$26.3K ﹤0.01%
6,695
+450
EML icon
3963
Eastern Company
EML
$113M
$26.3K ﹤0.01%
1,335
+62
RWM icon
3964
ProShares Short Russell2000
RWM
$133M
$26.2K ﹤0.01%
1,601
+589
UNB icon
3965
Union Bankshares
UNB
$107M
$26.2K ﹤0.01%
1,103
+365
CAPNR
3966
Cayson Acquisition Corp Right
CAPNR
$26.1K ﹤0.01%
+114,486
LATAW
3967
Galata Acquisition Corp II Warrant
LATAW
$26K ﹤0.01%
+74,188
LNSR icon
3968
LENSAR
LNSR
$141M
$25.7K ﹤0.01%
2,211
+203
KIO
3969
KKR Income Opportunities Fund
KIO
$459M
$25.5K ﹤0.01%
2,198
+314
AOMR
3970
Angel Oak Mortgage REIT
AOMR
$214M
$25.5K ﹤0.01%
2,958
-983
CSPI icon
3971
CSP Inc
CSPI
$86.3M
$25.3K ﹤0.01%
2,026
+566
MLP icon
3972
Maui Land & Pineapple Co
MLP
$325M
$25.1K ﹤0.01%
1,480
+47
KULR icon
3973
KULR Technology Group
KULR
$129M
$25K ﹤0.01%
8,444
+1,488
EPM icon
3974
Evolution Petroleum
EPM
$161M
$25K ﹤0.01%
7,054
-1,140
LUCD icon
3975
Lucid Diagnostics
LUCD
$184M
$24.9K ﹤0.01%
22,876
+8,984